(Updated - October 31, 2022 4:10 PM EDT)

Stifel analyst David Grossman initiates coverage on OptimizeRX (NASDAQ: OPRX) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE